The New Artificial Intelligentsia
By Ruha Benjamin,
Los Angeles Review of Books
| 10. 18. 2024
IN THE FALL OF 2016, I gave a talk at the Institute for Advanced Study in Princeton titled “Are Robots Racist?” Headlines such as “Can Computers Be Racist? The Human-Like Bias of Algorithms,” “Artificial Intelligence’s White Guy Problem,” and “Is an Algorithm Any Less Racist Than a Human?” had captured my attention in the months before. What better venue to discuss the growing concerns about emerging technologies, I thought, than an institution established during the early rise of fascism in Europe, which once housed intellectual giants like J. Robert Oppenheimer and Albert Einstein, and prides itself on “protecting and promoting independent inquiry.”
My initial remarks focused on how emerging technologies reflect and reproduce social inequities, using specific examples of what some termed “algorithmic discrimination” and “machine bias.” A lively discussion ensued. The most memorable exchange was with a mathematician who politely acknowledged the importance of the issues I raised but then assured me that “as AI advances, it will eventually show us how to address these problems.” Struck by his earnest faith in technology as a force for good...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...